Pathway Financial Advisors’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-7,850
Closed -$571K 156
2025
Q1
$571K Hold
7,850
0.1% 85
2024
Q4
$567K Sell
7,850
-60
-0.8% -$4.55K 0.13% 80
2024
Q3
$646K Buy
7,910
+60
+0.8% +$5.22K 0.17% 70
2024
Q2
$836K Hold
7,850
0.23% 52
2024
Q1
$763K Hold
7,850
0.21% 62
2023
Q4
$615K Hold
7,850
0.18% 67
2023
Q3
$492K Hold
7,850
0.17% 66
2023
Q2
$505K Hold
7,850
0.16% 65
2023
Q1
$416K Hold
7,850
0.14% 73
2022
Q4
$330K Hold
7,850
0.1% 86
2022
Q3
$287K Hold
7,850
0.1% 96
2022
Q2
$335K Hold
7,850
0.14% 85
2022
Q1
$422K Hold
7,850
0.16% 73
2021
Q4
$463K Buy
+7,850
New +$492K 0.17% 69
2021
Q1
$595K Hold
9,500
0.23% 49
2020
Q4
$539K Hold
9,500
0.22% 48
2020
Q3
$322K Hold
9,500
0.12% 67
2020
Q2
$307K Hold
9,500
0.09% 67
2020
Q1
$207K Hold
9,500
0.07% 91
2019
Q4
$293K Hold
9,500
0.08% 85
2019
Q3
$259K Buy
+9,500
New +$199K 0.07% 83
2018
Q3
Sell
-9,500
Closed -$164K 249
2018
Q2
$164K Hold
9,500
0.1% 108
2018
Q1
$193K Hold
9,500
0.11% 90
2017
Q4
$175K Buy
+9,500
New +$187K 0.1% 97

Other funds holding LRCX

Pathway Financial Advisors's LRCX Position: Q2 2025 in Review

Pathway Financial Advisors sold out of Lam Research (LRCX) in Q2 2025, closing a stake of 7,850 shares — an estimated $571K sold.

Pathway Financial Advisors first reported a position in LRCX in Q4 2017 and held it in 24 quarters. The position peaked at $836K in Q2 2024. 1,878 funds tracked by Wall St. Rank hold LRCX as of Q2 2025.

  • Pathway Financial Advisors reported no remaining Lam Research position as of Q2 2025 after selling out during the quarter.
  • Pathway Financial Advisors sold 7,850 Lam Research shares in Q2 2025, an estimated $571K.
  • Pathway Financial Advisors first reported a position in Lam Research in Q4 2017 and held it in 24 quarters.
  • Pathway Financial Advisors's Lam Research position peaked at $836K in Q2 2024.
  • 1,878 funds tracked by Wall St. Rank held Lam Research as of Q2 2025.

Based on Pathway Financial Advisors's 13F filing for Q2 2025, filed 25 Jul 2025.